We’re looking for a Research Associate In Silico to join our Oxford-based Bioinformatics Team.
Bring your scientific mindset, analytical skills, and attention to detail to help drive cancer target discovery. If you’re enthusiastic about research, self-motivated, and keen to learn new techniques, we’d love to hear from you.
About Oxford Biotherapeutics
Oxford BioTherapeutics (OBT) is a clinical-stage biotechnology company developing antibody therapeutics for the treatment of cancer. You will play an integral role in the pre-clinical development of novel immuno-oncology therapeutics. Our OGAP® platform is the world's largest, cancer specific, membrane protein library, directly measuring plasma membrane protein expression in patient tumors. OGAP is used to identify novel, highly tumor specific antigens for novel first-in-class ADC, Bispecific T-cell Engager (BITE®) and Chimeric Antigen Receptor (CAR) targets. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. Our clinical and pre-clinical pipeline of novel biologics is balanced between internal programs, focused on ADCs and checkpoint regulators, and externally partnered programs with key innovators in oncology such as Roche, Boehringer Ingelheim and Zymeworks.
For further information, please check our website www.oxfordbiotherapeutics.com
Purpose of the Role
In this role, you will support the discovery, investigation, and presentation of therapeutic cancer targets using bioinformatics-based approaches. Training will be provided as needed. This position would be ideal for a bioinformatics graduate with an interest in cancer biology and/or mass spectrometry-based proteomics.
Essential Duties and Responsibilities:
- Assist with bioinformatic pipeline including: Researching and annotating proteins of interest from internal and public resources.